标题
Aurora Kinases as Targets in Drug-Resistant Neuroblastoma Cells
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 9, Pages e108758
出版商
Public Library of Science (PLoS)
发表日期
2014-10-01
DOI
10.1371/journal.pone.0108758
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Karanjin interferes with ABCB1, ABCC1, and ABCG2
- (2016) Martin Michaelis et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Anticancer Effects of the Nitric Oxide-Modified Saquinavir Derivative Saquinavir-NO against Multidrug-Resistant Cancer Cells
- (2015) Florian Rothweiler et al. NEOPLASIA
- Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs
- (2014) Nadine Löschmann et al. Translational Oncology
- Chromosome Imbalances and Alterations of AURKA and MYCN Genes in Children with Neuroblastoma
- (2013) Nihal Inandiklioglu et al. Asian Pacific Journal of Cancer Prevention
- AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53
- (2013) Ondrej Kalous et al. BREAST CANCER RESEARCH AND TREATMENT
- Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma
- (2013) E Tavanti et al. BRITISH JOURNAL OF CANCER
- Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
- (2013) Markus Brockmann et al. CANCER CELL
- Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells
- (2013) Irena Horwacik et al. CANCER LETTERS
- Current and Future Strategies for Relapsed Neuroblastoma
- (2013) Daniel A. Morgenstern et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Targeting Aurora kinase-A downregulates cell proliferation and angiogenesis in neuroblastoma
- (2013) Carmelle Romain et al. JOURNAL OF PEDIATRIC SURGERY
- The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas
- (2012) Vikas Sehdev et al. CANCER
- Aurora kinase inhibitors: Progress towards the clinic
- (2012) Madhu Kollareddy et al. INVESTIGATIONAL NEW DRUGS
- Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines
- (2012) Jodi A. Muscal et al. INVESTIGATIONAL NEW DRUGS
- The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
- (2012) V. Sehdev et al. MOLECULAR CANCER THERAPEUTICS
- RGB marking with lentiviral vectors for multicolor clonal cell tracking
- (2012) Kristoffer Weber et al. Nature Protocols
- Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
- (2012) Julie R. Park et al. PEDIATRIC BLOOD & CANCER
- p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance
- (2012) Lindi Chen et al. Frontiers in Oncology
- Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma
- (2011) Wenqing Qi et al. BIOCHEMICAL PHARMACOLOGY
- Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer
- (2011) Hernan Carol et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo
- (2011) A. Faisal et al. MOLECULAR CANCER THERAPEUTICS
- Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
- (2011) M Michaelis et al. Cell Death & Disease
- A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma
- (2010) G. Gorgun et al. BLOOD
- Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53
- (2010) C F Cheok et al. CELL DEATH AND DIFFERENTIATION
- The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication
- (2010) Martin Michaelis et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- System-Level Analysis of Neuroblastoma Tumor-Initiating Cells Implicates AURKB as a Novel Drug Target for Neuroblastoma
- (2010) O. Morozova et al. CLINICAL CANCER RESEARCH
- High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma
- (2010) J. Carr-Wilkinson et al. CLINICAL CANCER RESEARCH
- Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia
- (2009) Nicholas J. Donato et al. BIOCHEMICAL PHARMACOLOGY
- Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
- (2009) Martin Michaelis et al. BIOCHEMICAL PHARMACOLOGY
- Reversal of P-glycoprotein-Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
- (2009) M. Michaelis et al. CANCER RESEARCH
- Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: new building blocks for cell marking and multi-gene analysis
- (2009) K Weber et al. GENE THERAPY
- p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cells
- (2009) Takayuki Ikezoe et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma
- (2009) X. Shang et al. MOLECULAR CANCER THERAPEUTICS
- Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells
- (2009) P. Kaestner et al. MOLECULAR CANCER THERAPEUTICS
- Identification of genes that confer tumor cell resistance to the Aurora B kinase inhibitor, AZD1152
- (2009) J Guo et al. PHARMACOGENOMICS JOURNAL
- Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemia
- (2008) K. Kojima et al. BLOOD
- Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells
- (2008) Altaf A. Dar et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started